In this study, combined with cervical cancer tissue chips and clinical baseline data analysis, we found that the expression level of ST3Gal IV in cervical cancer tissues was lower than that in adjacent tissues, and was negatively correlated with the malignancy of the tumor. This evidence concerns the gene ST3GAL4 and cervical carcinoma.